clinicaltrialsarena38m
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
clinicaltrialsarena2h
Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial
Spirovant has announced the commencement of its Phase I/II study with the first patient receiving a dose of SP-101 to treat ...
clinicaltrialsarena7h
GSK reports positive outcomes from Phase III multiple myeloma treatment trial
GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
clinicaltrialsarena5h
Patient experience in the spotlight at Clinical Trials in Oncology Europe 2024
The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI ...
clinicaltrialsarena19h
Amgen speaks out about bone density concerns with obesity drug
Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.